Kee H. Park

Incheon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 99 publications

Plasma glial fibrillary acidic protein as a potential biomarker for differentiating amyloid-negative subjective cognitive decline and mild cognitive impairment.

Plasma glial fibrillary acidic protein as a potential biomarker for differentiating amyloid-negative subjective cognitive decline and mild cognitive impairment.

Journal: Journal of Alzheimer's disease : JAD

Published: March 23, 2026

Erratum: Nationwide Survey on the Awareness of Mild Cognitive Impairment.

Erratum: Nationwide Survey on the Awareness of Mild Cognitive Impairment.

Journal: Dementia and neurocognitive disorders

Published: February 09, 2026

Association of circulating proteasome activity with Alzheimer's pathology and cognitive functions in APOE ε4 carriers.

Association of circulating proteasome activity with Alzheimer's pathology and cognitive functions in APOE ε4 carriers.

Journal: Alzheimer's research & therapy

Published: December 08, 2025

Impact of Cerebral Microbleeds on Tau-Associated Cognitive and Structural Decline.

Impact of Cerebral Microbleeds on Tau-Associated Cognitive and Structural Decline.

Journal: Neurology

Published: December 05, 2025

Clinical meaningfulness of anti-amyloid therapies in early Alzheimer's disease: Perspectives from the East and Southeast Asia region.

Clinical meaningfulness of anti-amyloid therapies in early Alzheimer's disease: Perspectives from the East and Southeast Asia region.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: November 19, 2025

Comparative Prognostic Performance of Hippocampal Volume and Plasma Biomarkers in Amyloid-Negative Subjective Cognitive Decline: A Four-Year Follow-up.

Comparative Prognostic Performance of Hippocampal Volume and Plasma Biomarkers in Amyloid-Negative Subjective Cognitive Decline: A Four-Year Follow-up.

Journal: Journal of clinical neurology (Seoul, Korea)

Published: November 11, 2025

Tau PET imaging as a mediator between glymphatic dysfunction and cognitive decline: a cross-sectional and longitudinal study.

Tau PET imaging as a mediator between glymphatic dysfunction and cognitive decline: a cross-sectional and longitudinal study.

Journal: European journal of nuclear medicine and molecular imaging

Published: August 30, 2025

A Protocol of Korean JOint RegistrY for ALZheimer's Treatment and Diagnostics (JOY-ALZ).

A Protocol of Korean JOint RegistrY for ALZheimer's Treatment and Diagnostics (JOY-ALZ).

Journal: Dementia and neurocognitive disorders

Published: August 25, 2025

Phase 3 randomized clinical trials of simufilam in mild-to-moderate Alzheimer's disease.

Phase 3 randomized clinical trials of simufilam in mild-to-moderate Alzheimer's disease.

Journal: The journal of prevention of Alzheimer's disease

Published: August 19, 2025

EEG-based detection of early functional brain changes in subjective cognitive decline: a prospective cohort study.

EEG-based detection of early functional brain changes in subjective cognitive decline: a prospective cohort study.

Journal: Alzheimer's research & therapy

Published: June 16, 2025

APOE Genotype Modifies the Predictive Performance of Plasma Biomarkers for Amyloid Plaque Burden in Subjective Cognitive Decline.

APOE Genotype Modifies the Predictive Performance of Plasma Biomarkers for Amyloid Plaque Burden in Subjective Cognitive Decline.

Journal: Journal of Korean medical science

Published: May 14, 2025

Standardized Procedures for Blood and Cerebrospinal Fluid Collection and Storage in Neurodegenerative Biomarker Research: A Comprehensive Review.

Standardized Procedures for Blood and Cerebrospinal Fluid Collection and Storage in Neurodegenerative Biomarker Research: A Comprehensive Review.

Journal: Dementia and neurocognitive disorders

Published: April 12, 2025

Showing 1-12 of 99

Last Updated: 09/26/2026